TARELLA, CORRADO
TARELLA, CORRADO
Dipartimento di Scienze della Salute
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular Lymphoma
2025 G. Lolli, A. Davini, V. Tabanelli, M. Sapienza, F. Melle, G. Motta, M. Del Corvo, A. Calleri, A. Vanazzi, P. Nierychlewska, A. Maraglino, M. Castelli, M. Quattrocchi, R. Chiarle, S. Pileri, C. Tarella, E. Derenzini
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials
2025 S. Viviani, C. Pavoni, S.F. Barrington, L. Guerra, H. Schöder, P. Johnson, A.A. Kirkwood, D.M. Stephens, J.W. Friedberg, S. Chauvie, M.V. Knopp, S. Luminari, D. Molin, P. Corradini, A. Gallamini, A. Rambaldi, C. Tarella
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study
2025 C. Tarella, S. Sammassimo, S. Frassoni, A. Dominietto, R. Cerretti, M.C. Micò, R. Pastano, M. Pennisi, M.C.D. Chio, C. Ghiggi, G. De Angelis, A. Algarotti, P. Chiusolo, E. Derenzini, S. Sica, P. Corradini, V. Bagnardi, E. Angelucci, A. Rambaldi, W.G. Arcese, A. Dodero, A. Bacigalupo
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two Cases
2024 E. Derenzini, A. Cignetti, V. Tabanelli, D. Gottardi, E. Gerbino, A. Vanazzi, S. Sammassimo, A. Maraglino, F. Melle, G. Motta, D. Malengo, E. Omodeo Salè, L. Bonello, R. Pastano, S. Pileri, F. Carnevale Schianca, C. Tarella
Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia
2024 C. Restelli, M. Ruella, L. Paruzzo, C. Tarella, P.G. Pelicci, E. Colombo
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
2024 S. Viviani, A. Vanazzi, S. Frassoni, C. Rusconi, A. Rossi, A. Romano, C. Patti, C. Schiavotto, R. Sorasio, V. Marasco, L. Lissandrini, D. Rapezzi, D. Gottardi, F. Cocito, A. Mulè, S. Leotta, G. Gini, M. Sorio, E. Derenzini, A. Rambaldi, V. Bagnardi, C. Tarella
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia
2024 C. Ronchini, F. Gigli, M. Fontanini, R. Furgi, V. Amato, F. Giglio, G. Gregato, F. Bertolini, M. Rondoni, F. Lanza, A. Billio, E. Derenzini, C. Tarella, P. Pelicci, Giuseppe, M. Alcalay, E. Todisco
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
2023 S. Mazzara, L. Travaini, F. Botta, C. Granata, G. Motta, F. Melle, S. Fiori, V. Tabanelli, A. Vanazzi, S. Ramadan, T. Radice, S. Raimondi, G. Lo Presti, M.E. Ferrari, B.A. Jereczek-Fossa, C. Tarella, F. Ceci, S. Pileri, E. Derenzini
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma]
2023 L. Lavinia Travaini, F. Botta, E. Derenzini, G. Lo Presti, M. Esmeralda Ferrari, L. Simona Air(`(o)) Farulla, T. Radice, S. Mazzara, C. Tarella, S. Pileri, S. Raimondi, F. Ceci
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
2022 V. Tabanelli, F. Melle, G. Motta, S. Mazzara, M. Fabbri, C. Agostinelli, A. Calleri, M. Del Corvo, S. Fiori, D. Lorenzini, A. Cesano, A. Chiappella, U. Vitolo, E. Derenzini, G.K. Griffin, S.J. Rodig, A. Vanazzi, E. Sabattini, C. Tarella, M.R. Sapienza, S.A. Pileri
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
2022 F.H. Schjesvold, M.-. Dimopoulos, S. Delimpasi, P. Robak, D. Coriu, W. Legiec, L. Pour, I. Spicka, T. Masszi, V. Doronin, J. Minarik, G. Salogub, Y. Alekseeva, A. Lazzaro, V. Maisnar, G. Mikala, L. Rosinol, A.M. Liberati, A. Symeonidis, V. Moody, M. Thuresson, C. Byrne, J. Harmenberg, N.A. Bakker, R. Hajek, M.-. Mateos, P.G. Richardson, P. Sonneveld, F. Schjesvold, A. Nikolayeva, W. Tomczak, L. Pour, I. Spicka, G. Mikala, L. Rosinol, T. Konstantinova, A. Symeonidis, M. Gatt, A. Illes, H. Abdulhaq, M. Dungarwalla, S. Grosicki, R. Hajek, X. Leleu, A. Myasnikov, P.G. Richardson, I. Avivi, D. Deeren, M. Gironella, M.T. Hernandez-Garcia, J. Martinez Lopez, M. Newinger-Porte, P. Ribas, O. Samoilova, E. Voog, M. Arnao-Herraiz, E. Carrillo-Cruz, P. Corradini, J. Dodlapati, M. Granell Gorrochategui, S.-. Huang, M. Jenner, L. Karlin, J.S. Kim, A. Kopacz, N. Medvedeva, C.-. Min, R. Mina, K. Palk, H.-. Shin, S.K. Sohn, J. Tache, A. Anagnostopoulos, J.-. Arguinano, M. Cavo, J. Filicko, M. Garnes, J. Halka, K. Herzog-Tzarfati, N. Ipatova, K. Kim, M.-. Krauth, I. Kryuchkova, M.C. Lazaroiu, M. Luppi, A. Proydakov, A. Rambaldi, M. Rudzianskiene, S.-. Yeh, M.M. Alcala-Pena, A. Alegre Amor, H. Alizadeh, M. Bendandi, G. Brearton, R. Brown, J. Cavet, N. Dally, M. Egyed, J.A. Hernandez-Rivas, A. Kaare, J.-. Karsenti, J. Kloczko, W. Kreisle, J.-. Lee, S. Machherndl-Spandl, S. Manda, I. Moiseev, J. Moreb, Z. Nagy, S. Nair, A. Oriol-Rocafiguera, M. Osswald, P. Otero-Rodriguez, V. Peceliunas, T. Plesner, P. Rey, G. Rossi, D. Stevens, C. Suriu, C. Tarella, A. Verlinden, A. Zannetti
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma
2022 F. Bonfiglio, A. Bruscaggin, F. Guidetti, L. Terzi di Bergamo, M.R. Faderl, V. Spina, A. Condoluci, L. Bonomini, G. Forestieri, R. Koch, D. Piffaretti, K. Pini, M.C. Pirosa, M.G. Cittone, A. Arribas, M. Lucioni, G. Ghilardi, W. Wu, L. Arcaini, M.J. Baptista, G. Bastidas, S. Beà, R. Boldorini, A. Broccoli, M.M. Bühler, V. Canzonieri, L. Cascione, L. Ceriani, S.B. Cogliatti, P. Corradini, E. Derenzini, L. Devizzi, S. Dietrich, A.R. Elia, F. Facchetti, G. Gaidano, J.F. Garcia, B. Gerber, P. Ghia, M. Gomes da Silva, G. Gritti, A. Guidetti, F. Hitz, G.G. Inghirami, M. Ladetto, A. López-Guillermo, E. Lucchini, A. Maiorana, R. Marasca, E. Matutes, V. Meignin, M. Merli, A.A. Moccia, M. Mollejo, C. Montalban, U. Novak, D.G. Oscier, F. Passamonti, F.A. Piazza, S. Pizzolitto, A. Rambaldi, E. Sabattini, G.A. Salles, E. Santambrogio, L. Scarfo, A. Stathis, G. Stussi, J.T. Geyer, G. Tapia, C. Tarella, C. Thieblemont, T. Tousseyn, A. Tucci, G. Vanini, C. Visco, U. Vitolo, R. Walewska, F. Zaja, T. Zenz, P.L. Zinzani, H. Khiabanian, A. Calcinotto, F. Bertoni, G. Bhagat, E. Campo, L. de Leval, S. Dirnhofer, S.A. Pileri, M.A. Piris, A. Traverse-Glehen, A. Tzankov, M. Paulli, M. Ponzoni, L. Mazzucchelli, F. Cavalli, E. Zucca, D. Rossi
Hematological disorders after salvage PARPi treatmentfor ovarian cancer: Cytogenetic and molecular defectsand clinical outcomes
2022 E. Todisco, F. Gigli, C. Ronchini, V. Amato, S. Sammassimo, R. Pastano, G. Parma, M. Teresa Lapresa, F. Bertolini, C. Corsini, G. Gregato, C. Poletti, P.G. Pelicci, M. Alcalay, N. Colombo, C. Tarella
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients
2022 E. Derenzini, A. Gueli, A. Risso, R. Bruna, D. Gottardi, A. Cignetti, S. Pileri, E.V. Avvedimento, C. Tarella
Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome
2021 R. Clari, C. Tarella, R. Giraudi, M.C. Torazza, E. Gallo, A. Lavacca, F. Fop, A. Mella, C. Dolla, L. Biancone
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas
2021 S. Ramadan, G. Ceparano, A. Cignetti, S. Sammassimo, V. Bagnardi, E. Pagan, D. Gottardi, S. Fiori, R. Passerini, T. Radice, G. Saglio, C. Tarella
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors : a single-center experience
2021 E. Todisco, F. Gigli, M. Mantiero, S. Sammassimo, R. Pastano, C. Ronchini, G. Parma, M.T. Lapresa, A.P. Iori, F. Bertolini, C. Corsini, G. Gregato, C. Poletti, N. Colombo, C. Tarella
HHV8-negative effusion-based large B cell lymphoma arising in chronic myeloid leukemia patients under dasatinib treatment : A report of two cases
2021 S. Fiori, E. Todisco, S. Ramadan, F. Gigli, P. Falco, A. Iurlo, C. Rampinelli, G. Croci, S.A. Pileri, C. Tarella
Peripheral t‐cell lymphoma, not otherwise specified : Clinical manifestations, diagnosis, and future treatment
2021 S.A. Pileri, V. Tabanelli, S. Fiori, A. Calleri, F. Melle, G. Motta, D. Lorenzini, C. Tarella, E. Derenzini
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma
2021 E. Derenzini, V. Tabanelli, S. Sammassimo, S. Mazzara, G. Motta, F. Melle, A. Vanazzi, A. Calleri, S. Fiori, M.C. Finazzi, M.C. Barbanti, S. Ramadan, S. Gandini, R. Pastano, A. Rambaldi, S. Pileri, C. Tarella